Cargando…

Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™

We recently reported the isolation and characterization of anti-SARS-CoV-2 antibodies from a phage display library built with the VH repertoire of a convalescent COVID-19 patient, paired with four naïve synthetic VL libraries. One of the antibodies, called IgG-A7, neutralized the Wuhan, Delta (B.1.6...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmán-Bringas, Omar U., Gómez-Castellano, Keyla M., González-González, Edith, Salinas-Trujano, Juana, Vázquez-Leyva, Said, Vallejo-Castillo, Luis, Pérez-Tapia, Sonia M., Almagro, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003557/
https://www.ncbi.nlm.nih.gov/pubmed/36902040
http://dx.doi.org/10.3390/ijms24054609
_version_ 1784904630815162368
author Guzmán-Bringas, Omar U.
Gómez-Castellano, Keyla M.
González-González, Edith
Salinas-Trujano, Juana
Vázquez-Leyva, Said
Vallejo-Castillo, Luis
Pérez-Tapia, Sonia M.
Almagro, Juan C.
author_facet Guzmán-Bringas, Omar U.
Gómez-Castellano, Keyla M.
González-González, Edith
Salinas-Trujano, Juana
Vázquez-Leyva, Said
Vallejo-Castillo, Luis
Pérez-Tapia, Sonia M.
Almagro, Juan C.
author_sort Guzmán-Bringas, Omar U.
collection PubMed
description We recently reported the isolation and characterization of anti-SARS-CoV-2 antibodies from a phage display library built with the VH repertoire of a convalescent COVID-19 patient, paired with four naïve synthetic VL libraries. One of the antibodies, called IgG-A7, neutralized the Wuhan, Delta (B.1.617.2) and Omicron (B.1.1.529) strains in authentic neutralization tests (PRNT). It also protected 100% transgenic mice expressing the human angiotensin-converting enzyme 2 (hACE-2) from SARS-CoV-2 infection. In this study, the four synthetic VL libraries were combined with the semi-synthetic VH repertoire of ALTHEA Gold Libraries™ to generate a set of fully naïve, general-purpose, libraries called ALTHEA Gold Plus Libraries™. Three out of 24 specific clones for the RBD isolated from the libraries, with affinity in the low nanomolar range and sub-optimal in vitro neutralization in PRNT, were affinity optimized via a method called “Rapid Affinity Maturation” (RAM). The final molecules reached sub-nanomolar neutralization potency, slightly superior to IgG-A7, while the developability profile over the parental molecules was improved. These results demonstrate that general-purpose libraries are a valuable source of potent neutralizing antibodies. Importantly, since general-purpose libraries are “ready-to-use”, it could expedite isolation of antibodies for rapidly evolving viruses such as SARS-CoV-2.
format Online
Article
Text
id pubmed-10003557
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100035572023-03-11 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™ Guzmán-Bringas, Omar U. Gómez-Castellano, Keyla M. González-González, Edith Salinas-Trujano, Juana Vázquez-Leyva, Said Vallejo-Castillo, Luis Pérez-Tapia, Sonia M. Almagro, Juan C. Int J Mol Sci Article We recently reported the isolation and characterization of anti-SARS-CoV-2 antibodies from a phage display library built with the VH repertoire of a convalescent COVID-19 patient, paired with four naïve synthetic VL libraries. One of the antibodies, called IgG-A7, neutralized the Wuhan, Delta (B.1.617.2) and Omicron (B.1.1.529) strains in authentic neutralization tests (PRNT). It also protected 100% transgenic mice expressing the human angiotensin-converting enzyme 2 (hACE-2) from SARS-CoV-2 infection. In this study, the four synthetic VL libraries were combined with the semi-synthetic VH repertoire of ALTHEA Gold Libraries™ to generate a set of fully naïve, general-purpose, libraries called ALTHEA Gold Plus Libraries™. Three out of 24 specific clones for the RBD isolated from the libraries, with affinity in the low nanomolar range and sub-optimal in vitro neutralization in PRNT, were affinity optimized via a method called “Rapid Affinity Maturation” (RAM). The final molecules reached sub-nanomolar neutralization potency, slightly superior to IgG-A7, while the developability profile over the parental molecules was improved. These results demonstrate that general-purpose libraries are a valuable source of potent neutralizing antibodies. Importantly, since general-purpose libraries are “ready-to-use”, it could expedite isolation of antibodies for rapidly evolving viruses such as SARS-CoV-2. MDPI 2023-02-27 /pmc/articles/PMC10003557/ /pubmed/36902040 http://dx.doi.org/10.3390/ijms24054609 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Guzmán-Bringas, Omar U.
Gómez-Castellano, Keyla M.
González-González, Edith
Salinas-Trujano, Juana
Vázquez-Leyva, Said
Vallejo-Castillo, Luis
Pérez-Tapia, Sonia M.
Almagro, Juan C.
Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
title Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
title_full Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
title_fullStr Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
title_full_unstemmed Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
title_short Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™
title_sort discovery and optimization of neutralizing sars-cov-2 antibodies using althea gold plus libraries™
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003557/
https://www.ncbi.nlm.nih.gov/pubmed/36902040
http://dx.doi.org/10.3390/ijms24054609
work_keys_str_mv AT guzmanbringasomaru discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries
AT gomezcastellanokeylam discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries
AT gonzalezgonzalezedith discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries
AT salinastrujanojuana discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries
AT vazquezleyvasaid discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries
AT vallejocastilloluis discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries
AT pereztapiasoniam discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries
AT almagrojuanc discoveryandoptimizationofneutralizingsarscov2antibodiesusingaltheagoldpluslibraries